79-year-old Jupiter resident Chantal Desgroseillers receives Eli Lilly's newly approved Alzheimer's drug Kisunla for early-stage symptoms.
79-year-old Jupiter resident Chantal Desgroseillers became one of the first people to receive Eli Lilly and Company's newly approved Alzheimer's drug, Kisunla (donanemab), which targets amyloid in the brain. This monthly IV infusion is hoped to slow Alzheimer's progression, offering new hope to patients. Desgroseillers, who has early Alzheimer's symptoms, is optimistic about the treatment.
July 26, 2024
3 Articles